Safety and preliminary efficacy in patients with relapsed/refractory mantle cell lymphoma receiving lisocabtagene maraleucel in TRANSCEND NHL 001 Meeting Abstract


Authors: Wang, M.; Gordon, L. I.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Ghosh, N.; Lunning, M.; Maloney, D.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K.; Dehner, C.; Siddiqi, T.
Abstract Title: Safety and preliminary efficacy in patients with relapsed/refractory mantle cell lymphoma receiving lisocabtagene maraleucel in TRANSCEND NHL 001
Meeting Title: 15th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 37
Issue: Suppl. 2
Meeting Dates: 2019 Jun 18-22
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2019-06-01
Start Page: 301
End Page: 303
Language: English
ACCESSION: 136932384
DOI: 10.1002/hon.111_2630
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 31187525
DOI/URL:
Notes: Meeting abstract: 247 -- Accession Number: 136932384 -- Entry Date: In Process -- Revision Date: 20190617 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S1 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba